SFG Wealth Management LLC. Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SFG Wealth Management LLC. raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 24.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 507 shares of the medical equipment provider’s stock after purchasing an additional 100 shares during the quarter. SFG Wealth Management LLC.’s holdings in Intuitive Surgical were worth $251,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in ISRG. Vanguard Group Inc. boosted its holdings in Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after acquiring an additional 360,591 shares during the period. Geode Capital Management LLC raised its position in Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after purchasing an additional 243,802 shares in the last quarter. Fisher Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after buying an additional 86,488 shares during the period. Norges Bank bought a new position in shares of Intuitive Surgical during the 4th quarter worth $2,401,493,000. Finally, Invesco Ltd. raised its holdings in shares of Intuitive Surgical by 7.7% in the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock valued at $2,165,184,000 after acquiring an additional 295,025 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 215 shares of the business’s stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $549.06, for a total transaction of $118,047.90. Following the completion of the sale, the senior vice president now owns 1,768 shares of the company’s stock, valued at $970,738.08. The trade was a 10.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,998 shares of company stock worth $2,611,577. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 0.3%

ISRG stock opened at $521.63 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00. The firm has a market cap of $186.96 billion, a P/E ratio of 76.49, a PEG ratio of 5.55 and a beta of 1.67. The company’s 50-day simple moving average is $530.03 and its 200-day simple moving average is $536.86.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the business posted $1.50 earnings per share. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on ISRG. Royal Bank Of Canada reduced their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Piper Sandler cut their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a “hold” rating to a “sell” rating and dropped their target price for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Truist Financial cut their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research report on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $588.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.